Harri Hemila and Elizabeth Chalker at the University of Helsinki conducted the most authoritative review of vitamin C and the common cold ever published. Their Cochrane systematic review pooled data from 29 placebo-controlled trial comparisons involving 11,306 participants who took at least 200 mg of vitamin C daily.

The review found that taking vitamin C every day shortened colds by 8% in adults and 14% in children. For children taking 1 to 2 grams per day, colds were 18% shorter. That means if a child''s cold normally lasted 10 days, it would last about 8 days instead. The review also found that cold severity was reduced.

The sheer scale of this review - thousands of participants across decades of research - makes this finding highly reliable. The consistent reduction in duration suggests vitamin C helps the body fight off cold viruses faster once infected.

Within the 2013 Cochrane review, Hemila and Chalker identified a striking subgroup finding. Five trials focused specifically on people under severe short-term physical stress - marathon runners, cross-country skiers, and soldiers doing subarctic training exercises. Among these 598 participants, those taking vitamin C had only about half the risk of catching a cold compared to those taking a placebo.

This 52% reduction in cold incidence is far larger than what was seen in the general population. The finding is biologically plausible because intense exercise temporarily suppresses the immune system, and vitamin C is known to be rapidly depleted during physical stress.

This subgroup result has been replicated across multiple independent studies in different countries and with different types of athletes and soldiers. The Cochrane reviewers noted that while routine supplementation is not justified for everyone, it may be useful for people exposed to brief periods of severe physical exercise.

E.M. Peters and colleagues at the University of the Witwatersrand in Johannesburg designed this study around the Comrades Marathon, a grueling 90-kilometer ultramarathon. They gave runners either 600 mg of vitamin C per day or a placebo for 21 days leading up to the race, then tracked who developed upper respiratory tract infection symptoms afterward.

In the placebo group, 68% of runners got sick after the race. In the vitamin C group, only 33% did. Vitamin C roughly halved the chance of getting sick after extreme endurance exercise.

This study was important because it showed that even a relatively moderate dose of vitamin C (600 mg, compared to the multi-gram doses often advocated) could have a large protective effect when the body is under extreme physical stress.

T.W. Anderson and colleagues at the University of Toronto conducted one of the first large-scale, double-blind, placebo-controlled trials of vitamin C for the common cold. Published in the Canadian Medical Association Journal in 1972, the study enrolled 818 volunteers who took either 1 gram of vitamin C per day or a placebo throughout the winter cold season.

The overall number of colds was only slightly lower in the vitamin C group. However, participants taking vitamin C experienced approximately 30% fewer total days of disability - meaning days when they were confined to the house or unable to work. This difference was highly statistically significant.

The 30% reduction in disability days is a practically important finding - it means people got back to normal life faster even if they still caught a cold.

Harri Hemila and Elizabeth Chalker published this updated meta-analysis in BMC Public Health in December 2023, focusing specifically on the severity of colds rather than just their duration. They analyzed 10 randomized, double-blind, placebo-controlled trials that reported severity outcomes using validated scales.

The pooled result showed a 15% reduction in cold severity among people taking at least 1 gram of vitamin C per day. The effect was more pronounced for severe symptoms. When researchers looked at the most debilitating aspects of colds - like days confined indoors or spent in bed - the reductions were larger than for mild symptoms like a runny nose.

This analysis included 15 comparisons from these 10 trials, all of which were randomized and double-blind, meaning neither the participants nor the researchers knew who was getting vitamin C and who was getting the placebo.

Several controlled trials examined whether higher doses of vitamin C produce greater benefits when treating active colds. The Karlowski 1975 trial found that adults taking 6 grams per day experienced roughly double the benefit in cold duration reduction compared to those taking 3 grams per day. Anderson''s 1974 trial found that a single 8-gram dose at the onset of a cold was significantly more effective than a 4-gram dose.

In the Anderson trial, 46% of participants in the 8-gram group had colds lasting only one day, compared to 39% in the 4-gram group. When treatment was started within 24 hours of the first symptoms, vitamin C-treated colds lasted an average of 3.6 days, while colds treated with conventional remedies lasted 6.9 days - a 48% reduction.

When taking more of a substance produces a bigger effect in a predictable way, scientists call this a "biological gradient." This pattern strengthens the argument that vitamin C is actually causing the benefit rather than the improvement being due to chance.

Kim and colleagues conducted a randomized, double-blind, placebo-controlled trial at the Korea Army Training Centre in 2018, published in BMJ Military Health in 2020. They enrolled 1,444 soldiers with an average age of 21.7 years undergoing 30 days of intensive basic military training - a period of physical and psychological stress known to increase susceptibility to respiratory infections.

Participants received either 2,000 mg of vitamin C three times daily (totaling 6 grams per day) or a placebo. The soldiers who received vitamin C had a lower incidence of common colds. The protective effect was particularly strong among participants who had never smoked.

Military recruits undergoing basic training experience sleep deprivation, physical exhaustion, and crowded living conditions - all factors that increase cold risk. The study adds to the body of evidence showing that vitamin C is most protective in populations under physical stress.

Anitra Carr and Silvia Maggini published a comprehensive review in the journal Nutrients in 2017 examining the biological mechanisms by which vitamin C supports immune function. They found that immune cells, particularly white blood cells called neutrophils and lymphocytes (the cells that fight infections), actively transport vitamin C into themselves and maintain internal concentrations 10 to 100 times higher than what is found in the blood.

This accumulation is not accidental. White blood cells called neutrophils, which are the first responders that engulf and destroy invading viruses, need vitamin C to produce the chemicals they use to kill pathogens. Vitamin C also helps the body produce more lymphocytes, the cells responsible for making antibodies and killing virus-infected cells.

During infections, vitamin C levels in the blood and in immune cells drop rapidly, sometimes reaching levels seen in scurvy (the disease caused by severe vitamin C deficiency). This suggests that supplementation during a cold may be restoring levels that infection has depleted.

Linus Pauling, the only person to win two unshared Nobel Prizes (Chemistry in 1954 and Peace in 1962), became interested in vitamin C after biochemist Irwin Stone suggested that high-dose vitamin C could extend lifespan. Pauling began taking 3 grams daily and published his book "Vitamin C and the Common Cold" in 1970.

In 1971, Pauling conducted what was essentially an early meta-analysis of four placebo-controlled trials. He calculated that the probability of the observed reductions in cold severity being due to chance was extremely small - less than 3 in 100,000.

While the medical establishment was largely skeptical, Pauling''s advocacy triggered an enormous wave of research. Dozens of randomized controlled trials followed over the next five decades. The modern Cochrane reviews ultimately confirmed that Pauling was partially right: vitamin C does reduce cold duration and severity, though the effect is more modest than he claimed. His intuition about physically stressed populations was strongly validated by studies in marathon runners and soldiers.

Sasazuki and colleagues conducted one of the longest randomized controlled trials of vitamin C and the common cold, running for five years in a village in the Akita prefecture of Japan. Published in the European Journal of Clinical Nutrition in 2006, this trial assigned participants to either a high-dose group (500 mg per day) or a low-dose group (50 mg per day).

Of 439 eligible subjects, 244 completed the full trial. The high-dose group experienced 17.1 common colds per 1,000 person-months, while the low-dose group experienced 21.3 colds per 1,000 person-months - a statistically significant reduction in cold frequency of roughly 20%.

This trial is notable for its unusually long duration. Most vitamin C studies last only a few months, but this one tracked participants across five complete cold seasons. The long follow-up period gives more confidence that the results reflect a real and sustained effect rather than a short-term anomaly.